Vincent T. DeVita

19.5k total citations · 4 hit papers
191 papers, 14.2k citations indexed

About

Vincent T. DeVita is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vincent T. DeVita has authored 191 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pathology and Forensic Medicine, 66 papers in Oncology and 43 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vincent T. DeVita's work include Lymphoma Diagnosis and Treatment (72 papers), Chronic Lymphocytic Leukemia Research (35 papers) and Lung Cancer Treatments and Mutations (27 papers). Vincent T. DeVita is often cited by papers focused on Lymphoma Diagnosis and Treatment (72 papers), Chronic Lymphocytic Leukemia Research (35 papers) and Lung Cancer Treatments and Mutations (27 papers). Vincent T. DeVita collaborates with scholars based in United States, Malaysia and United Kingdom. Vincent T. DeVita's co-authors include Robert C. Young, Edward Chu, George P. Canellos, S M Hubbard, Paul P. Carbone, Steven A. Rosenberg, Bruce A. Chabner, S Hellman, S A Rosenberg and Charles L. Vogel and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Vincent T. DeVita

190 papers receiving 12.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A History of Cancer Chemotherapy

2008 1.3k citations Vincent T. DeVita, Edward Chu profile →
Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1970 1.1k citations Vincent T. DeVita et al. profile →
THE SPECTRUM OF THE DISEASE IN 98 PATIENTS

1970 798 citations Robert C. Young, Vincent T. DeVita et al. profile →
Important Advances in Oncology

1991 559 citations Vincent T. DeVita et al. profile →

Peers

Countries citing papers authored by Vincent T. DeVita

Since Specialization

Citations

This map shows the geographic impact of Vincent T. DeVita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent T. DeVita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent T. DeVita more than expected).

Fields of papers citing papers by Vincent T. DeVita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent T. DeVita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent T. DeVita. The network helps show where Vincent T. DeVita may publish in the future.

Co-authorship network of co-authors of Vincent T. DeVita

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent T. DeVita. A scholar is included among the top collaborators of Vincent T. DeVita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent T. DeVita. Vincent T. DeVita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cancer : principles & practice of oncology : primer of the molecular biology of cancer/ editors, Vincent T. DeVita, Jr, Theodore S. Lawrence, Steven A. Rosenberg; with 82 contributing authors 2015 ·Vincent T. DeVita, Theodore S. Lawrence, Steven A. Rosenberg	1
2	Role of Chemotherapy in Hodgkin’s Lymphoma 2009 ·The Cancer Journal ·(unknown), John E. Janik, Dan L. Longo, Vincent T. DeVita	14
3	Physician's cancer chemotherapy drug manual 2008 2003 ·Medical Entomology and Zoology ·Edward Chu, Vincent T. DeVita	86
4	FROM THE EDITORS 2002 ·The Cancer Journal ·Vincent T. DeVita, Samuel Hellmän, Steven A. Rosenberg	1
5	A Perspective on the War on Cancel 2002 ·The Cancer Journal ·Vincent T. DeVita	10
6	Cutaneous T cell lymphoma : basic and clinically relevant biology 2001 ·New York Academy of Sciences eBooks ·Richard L. Edelson, Vincent T. DeVita	1
7	Hodgkin's Disease 1993 ·New England Journal of Medicine ·Alastair J.J. Wood, Vincent T. DeVita, S M Hubbard	69
8	Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP. 1991 ·Journal of Clinical Oncology ·Dan L. Longo, P L Duffey, Vincent T. DeVita, Peter H. Wiernik, S M Hubbard, John C. Phares, Anne Bastian, Elaine S. Jaffe, Robert C. Young	42
9	The influence of information on drug resistance on protocol design 1991 ·Annals of Oncology ·Vincent T. DeVita	19
10	Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas 1991 ·Annals of Oncology ·(unknown), Dan L. Longo, Vincent T. DeVita, S M Hubbard, Thomas P. Miller, Robert C. Young	14
11	Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. 1991 ·Journal of Clinical Oncology ·Daniele Longo, Vincent T. DeVita, P L Duffey, Margaret N. Wesley, Daniel C. Ihde, S M Hubbard, (unknown), Elaine S. Jaffe, Jeffrey Cossman, Richard I. Fisher	179
12	Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. 1989 ·Journal of Clinical Oncology ·Dan L. Longo, Eli Glatstein, P L Duffey, Daniel C. Ihde, S M Hubbard, R I Fisher, Elaine S. Jaffe, (unknown), Robert C. Young, Vincent T. DeVita	91
13	Keeping up with the cancer literature--PDQ ACCESS. 1988 ·Journal of Clinical Oncology ·David J. Perry, (unknown), S M Hubbard, (unknown), Vincent T. DeVita	3
14	Cancer drug development 1979 ·Academic Press eBooks ·Vincent T. DeVita, Harris Busch	9
15	The treatment of Hodgkin's disease 1977 ·Current Problems in Cancer ·Robert C. Young, Tom Anderson, Vincent T. DeVita	11
16	The design of clinical trials in the therapy of ovarian carcinoma 1974 ·American Journal of Obstetrics and Gynecology ·Robert C. Young, Vincent T. DeVita	3
17	Cyclical Combination Chemotherapy for Advanced Breast Carcinoma 1974 ·BMJ ·George P. Canellos, Vincent T. DeVita, G. Lennard Gold, Bruce A. Chabner, Philip S. Schein, Robert C. Young	83
18	Anergy and tryptophan metabolism in Hodgkin’s disease 1971 ·American Journal of Clinical Nutrition ·Vincent T. DeVita, Bruce A. Chabner, David M. Livingston, Vincent T. Oliverio	13
19	Combination Chemotherapy With Nitrogen Mustard, Vincristine, Procarbazine and Prednisone in Previously Treated Patients With Hodgkin’s Disease 1970 ·Blood ·Stanley Lowenbraun, Vincent T. DeVita, Arthur A. Serpick	54
20	The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo. 1969 ·PubMed ·Robert C. Young, Vincent T. DeVita, Seymour Perry	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact